Mechanisms of cryoablation: clinical consequences on malignant tumors.
Baust JG, Gage AA, Bjerklund Johansen TE, Baust JM.
Cryobiology. 2014 Feb;68(1):1-11. doi: 10.1016/j.cryobiol.2013.11.001. Epub 2013 Nov 13.
Progressing prostate carcinoma.
Haut MJ, Harryhill JF, Rosenstock J, Warhol MJ, Vitti R.
Oncologist. 2001;6(2):183-96. doi: 10.1634/theoncologist.6-2-183.
Issues critical to the successful application of cryosurgical ablation of the prostate.
Baust JG, Gage AA, Klossner D, Clarke D, Miller R, Cohen J, Katz A, Polascik T, Clarke H, Baust JM.
Technol Cancer Res Treat. 2007 Apr;6(2):97-109. doi: 10.1177/153303460700600206.
Cryosurgical palliation of metastatic neuroendocrine tumors resistant to conventional therapy.
Bilchik AJ, Sarantou T, Foshag LJ, Giuliano AE, Ramming KP.
Surgery. 1997 Dec;122(6):1040-7; discussion 1047-8. doi: 10.1016/s0039-6060(97)90207-5.
Cryosurgery in the treatment of cancer.
Gage AA.
Surg Gynecol Obstet. 1992 Jan;174(1):73-92.
Cryosurgery of malignant and premalignant diseases of the skin: a simple approach.
Sinclair RD, Dawber RP.
Australas J Dermatol. 1995 Aug;36(3):133-42. doi: 10.1111/j.1440-0960.1995.tb00955.x.
Oncological and functional results of cryosurgical therapy of enchondromas and chondrosarcomas grade 1.
van der Geest IC, de Valk MH, de Rooy JW, Pruszczynski M, Veth RP, Schreuder HW.
J Surg Oncol. 2008 Nov 1;98(6):421-6. doi: 10.1002/jso.21122.
Targeted-cryosurgical ablation of the prostate with androgen deprivation therapy: quality of life in high-risk prostate cancer patients.
Kang SH, Kim JW, Bae JH, Park HS, Moon DG, Yoon DK, Cheon J, Kim JJ.
Asian J Androl. 2006 Sep;8(5):629-36. doi: 10.1111/j.1745-7262.2006.00176.x.
Cryosurgical iridocyclectomy.
Baum JL.
Arch Ophthalmol. 1978 Jun;96(6):1065-6. doi: 10.1001/archopht.1978.03910050585019.
Cryosurgery in the treatment of oro-facial lesions.
Bansal A, Jain S, Gupta S.
Indian J Dent Res. 2012 Mar-Apr;23(2):297. doi: 10.4103/0970-9290.100468.
